Campillo Dav\uf3, Diana

Roex, Gils

Smits, Evelien

Van Acker, Heleen

Van Tendeloo, Vigor

Versteven, Maarten

Abstract: Cytokines of the common gamma-chain receptor family, comprising interleukin (IL)-2, IL-4, IL-7, IL-9, IL-15 and IL-21, are vital with respect to organizing and sustaining healthy immune cell functions. Supporting the anticancer immune response, these cytokines inspire great interest for their use as vaccine adjuvants and cancer immunotherapies. It is against this background that gamma delta (gamma delta) T cells, as special-force soldiers and natural contributors of the tumor immunosurveillance, also received a lot of attention the last decade. As gamma delta T cell-based cancer trials are coming of age, this present review focusses on the effects of the different cytokines of the common gamma-chain receptor family on gamma delta T cells with respect to boosting gamma delta T cells as a therapeutic target in cancer immunotherapy. This review also gathers data that IL-15 in particular exhibits key features for augmenting the anti-tumor activity of effector killer gamma delta T cells whilst overcoming the myriad of immune escape mechanisms used by cancer cells

The role of the common gamma-chain family cytokines in <tex>\gamma\delta$</tex> T cell-based anti-cancer immunotherapy

Abstract

Similar works

Full text

Available Versions

Institutional Repository Universiteit Antwerpen